You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination

 

Online download statistics by month:

Online download statistics by month: December 2023 to July 2025

AbstractFullPdf
Dec 2023628633374
Jan 2024264264180
Feb 202410510563
Mar 2024121122142
Apr 2024140140116
May 2024999975
Jun 202411111382
Jul 2024147148105
Aug 2024989669
Sep 2024666655
Oct 2024969674
Nov 2024194195144
Dec 2024171174136
Jan 2025217217179
Feb 2025218218147
Mar 202510510584
Apr 202512312380
May 2025939578
Jun 2025646452
Jul 2025110
Total306130742235